compound tirzepatide stopping FDA Says Compounded Must Exit the Market Millions of people are taking

Study size

It is characterized by recurrent episodes of uncontrolled eating and significant distress, and is associated with psychiatric comorbidities (e.g., depression, anxiety, and substance use) and increased metabolic risk [131]

Autoimmune considerations : There is no evidence that GLP-1 receptor agonists worsen autoimmune thyroid disease or trigger new-onset Hashimoto's thyroiditis

a 2025 IV pilot in two adults used 10 mg and 20 mg single infusions and reported no adverse effects (Lee et al., Alternative Therapies in Health and Medicine)

Studies have indicated improvements in cardiovascular risk factors, such as blood pressure and cholesterol levels, among individuals taking Semaglutide

Continuing to eat small, frequent meals is also crucial